Health Tech Capitol | Uncategorized
1
archive,paged,category,category-uncategorized,category-1,paged-16,category-paged-16,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Uncategorized

SAN DIEGO--ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD)...

Semba Biosciences announced recently that it received an equity investment from Tosoh Bioscience, which intends to acquire the company, though no additional details were provided. According to a release, the two companies have been collaborating on various biomanufacturing projects since 2007. “We are extremely pleased to team up...

San Francisco, Calif. – Dignity Health, one of the nation’s largest health systems, and Propeller Health, a leading digital therapeutics company, announced today the results of their new published, peer-reviewed study, which indicates that asthma-related emergency room visits declined by more than half for people who used connected,...

FLORHAM PARK, N.J. -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, announces the initiation of Cohort 6 of its ongoing Phase 1b trial evaluating CLR 131 for the treatment of...

New research from Propeller Health, the University of Wisconsin-Madison and the University of California, Berkeley, is the first nationwide study to show an association between daily air pollution and rescue inhaler use using data obtained objectively from digital medicines. The study, conducted from 2012 to 2017 on more than 2,800 people...